Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 6/20 | 0.54 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.50 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | ANPEP | P15144 | 1/20 | 0.48 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.48 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.48 |
| ▸ | TGM2 | P21980 | 1/20 | 0.48 |
| ▸ | DPP4 | P27487 | 1/20 | 0.47 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.47 |
| ▸ | MMP2 | P08253 | 1/20 | 0.47 |
| ▸ | MMP9 | P14780 | 1/20 | 0.47 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.47 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15802483 | 0.82 | FOLH1 (0.45) | FOLH1DPP8DPP7HTTANPEP | |
| SCHEMBL1025893 | 0.82 | SLC1A3 (0.53) | FOLH1DPP8DPP7HTTANPEP | |
| SCHEMBL12831893 | 0.81 | FOLH1 (0.57) | FOLH1DPP8DPP7HTTANPEP | |
| SCHEMBL15802467 | 0.80 | DPP8 (0.44) | FOLH1DPP8DPP7HTTANPEP | |
| SCHEMBL19726693 | 0.79 | FOLH1 (0.54) | FOLH1DPP8DPP7HTTANPEP | |
| SCHEMBL15802459 | 0.79 | MAPT (0.49) | FOLH1HTTSLC1A3SLC1A1 | |
| SCHEMBL21460905 | 0.78 | MAPT (0.51) | FOLH1DPP8DPP7HTTSLC1A3 | |
| SCHEMBL21460902 | 0.78 | MAPT (0.51) | FOLH1DPP8DPP7HTTSLC1A3 | |
| SCHEMBL4177384 | 0.78 | DPP8 (0.68) | FOLH1DPP8DPP7HTTANPEP | |
| SCHEMBL4177378 | 0.78 | DPP8 (0.68) | FOLH1DPP8DPP7HTTANPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7199268-B2 | Process for the production of dendritic trimesic acid triamides | SCHERING AKTIENGESELLSCHAFT (DE) | 2007-04-03 | — | — | US | disclosed |
| US-20050238615-A1 | Process for the production of dendritic trimesic acid triamides | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2005-10-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050238615-A1 | Process for the production of dendritic trimesic acid triamides | TRIM4, TRIM59, TRIM58 | FOLH1 1340/4885DPP8 1033/4885DPP7 1076/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.